Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Qiagen and Lepu Team Up to Provide Cardiac Diagnostic Tests in China

publication date: Sep 14, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Qiagen, the Dutch medical device company, has teamed up with Lepu Medical Technology (Beijing). The two companies will combine their diagnostic devices, which Lepu will then market in China. The two devices are Qiagen's ESEQuant Lateral Flow System, a test reader, and Lepu's cardiac marker tests that diagnose acute myocardial infarction. Lepu will market the combination under the name Lepu Quant-Gold. More details....

Stock Symbols: (NSDQ: QGEN) (SHE: 300003)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners